• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL CADD ADMINISTRATION SET; SET, ADMINISTRAION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL CADD ADMINISTRATION SET; SET, ADMINISTRAION, INTRAVASCULAR Back to Search Results
Model Number 21-7395-24
Medical Device Problem Codes Crack (1135); Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/08/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a customer had an incident whereby the tubing cracked open in the middle of the set, not near any connection.The patient was home and it happened overnight while he was sleeping.Not sure of the cause.The reporter had no other complaints and we haven't seen anything like this before.The patient was not harmed and treatment was not delayed.We are unsure of how long the tubing was leaking so we have no way of knowing how much of the medication was lost and not administered to the patient.No patient injury was reported.
 
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Additional Manufacturer Narrative
Other, other text: the sample returned, was received without its original packaging, in used condition, and decontaminated.The complaint returned units were visually inspected under normal conditions of illumination according to procedure no obstructions or other defects were detected in either of the joins of the product are visible.The tube presents a slit.The reported failure mode is confirmed.Production personnel wipes the excessive solvent from inside diameter of tube to prevent occlusion or hourglasses.Production personnel turn tube back and forth for a minimum of two seconds.Remove immediately after two seconds with a maximum of 5 seconds in the solvent according to procedure.Production performs 100% visual inspection to assure that that tubing does not display excessive solvent.Production performs a delivery accuracy test to (b)(4) units at shift start up, the end of every shift, the beginning of every job, the end of every job; a new lot of materials components or equipment adjustment.Quality personnel takes a sample of fifteen units every two hours, prior to placing product in bag, verify that tubes are not occluded, tubes are not kinked or coiled too tightly, tubes shall not have flat spots, or other damage.The proper performance of the tests and that the results are within specification.Root causes cannot be associated with the manufacturing process.Device history record review was conducted which indicated all inspections were completed and no issues were noted during manufacture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD ADMINISTRATION SET
Common Device Name
SET, ADMINISTRAION, INTRAVASCULAR
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
jim vegel
6000 nathan lane north
minneapolis, MN 55442
MDR Report Key16060878
Report Number3012307300-2022-28201
Device Sequence Number12433999
Product Code FPA
UDI-Device Identifier10610586027543
UDI-Public10610586027543
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
K040636
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/17/2024
Device Model Number21-7395-24
Device Catalogue Number21-7395-24
Device Lot Number3757210
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/09/2022
Supplement Date Received by Manufacturer02/24/2023
Initial Report FDA Received Date12/28/2022
Supplement Report FDA Received Date03/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/06/2019
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexMale
-
-